Event

P17 PBI-4425, a Novel First-in-Class Anti-Inflammatory/Anti-Fibrotic Compound, Inhibits Collagen I and CTGF Production in Human Fibroblasts, and Reduces Lung Fibrosis in the Bleomycin-Induced Lung Fibrosis Model